StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
CAPRO.BO$49.04+4.21%
Fair $49.04+0.0%

CAPRO.BO

Caprolactam Chemicals Limited

Basic Materials / ChemicalsBSE

$49.04

+1.98 (+4.21%)

Fairly Valued+0.0%Fair Value $49.04Fund rank 25/100 · Data gapFallback financials|
SA 26/D
F-Score: 1/9
Declining RevenueLow Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 17%

FCF escenarios

weak_data · normalized FCF $-13.0M · quality 39.3/100

Data gap 25/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 21/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

26/100

D

Piotroski

1/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 2unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Sector-specific commodity mid-cycle model required: targets are disabled until normalized cycle price/cost-curve/reserve data exists. Revenue has declined for 2 consecutive years ROE is -14.7%, below the 5% threshold
Thesis & Journal · CAPRO.BOLocal privado en este navegador · Caprolactam Chemicals Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$226M

P/E

47.6x

↑

EV/EBITDA

20.3x

↑

ROE

-14.7%

↓

Gross Margin

80.1%

↑

Debt/Equity

1.80

↑
52-Week Range$49
$38$81

TradingView lightweight chart

CAPRO.BO price, volumen y niveles de valoración

Último $49.04Periodo -15.4%
Fair value: $49.04

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+48.2%

FCF CAGR

—

FCF margin

-33.2%

FCF / Net income

3.15x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $67.4M · net income $-7.1M · FCF $-22.3M

2022-FY → 2025-FY

Gross margin

80.1%+33.8% pts

Operating margin

-1.0%+59.3% pts

Net margin

-10.5%+51.5% pts

FCF margin

-33.2%+49.3% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$67.4M$67.4M$69.6M$98.4M$20.7M
Net Income$-7.1M$-7.1M$2.0M$25.5M$-12.8M
EBITDA$15.3M$15.3M$23.5M$46.9M$-1.6M
EPS-1.54-1.540.435.54-2.79
Gross Margin80.1%80.1%93.0%77.9%46.3%
Operating Margin-1.0%-1.0%11.0%35.8%-60.3%
Net Margin-10.5%-10.5%2.8%25.9%-62.0%
Balance Sheet
Debt/Equity1.801.801.061.061.34
Current Ratio0.500.50———
Cash Flow
Free Cash Flow$-22.3M$-22.3M$1.7M$-13.0M$-17.1M
Returns
ROE-14.7%-14.7%3.6%47.7%-45.8%
Valuation
P/E47.6147.61———
EV/EBITDA20.3420.34———
P/B4.674.67———
Growth & Yield
Revenue Growth-3.1%-3.1%-29.3%375.7%—
EPS Growth-458.1%-458.1%-92.2%298.8%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +14.1%

Total return

+14.1%

Start / end P/E

n/dx → n/dx

EPS bridge

0.43 → -1.54

Residual

+14.1%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term+14.1%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.